| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.43 | 5e-10 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-10 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-09 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.39 | 6e-08 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |